-2.75 (-0.17%) Sun Pharmaceutical Industries is going to consider a proposal for buyback of shares next week. The meeting of board of directors of the company is scheduled to be held on March 17 to consider and if deemed fit, to approve, the proposal for buyback of fully paid-up equity shares of the company, which would include maximum amount, maximum number of equity shares, mode of buy-back and other matters.
Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.